Page last updated: 2024-08-26

peptide elongation factor 2 and Colonic Neoplasms

peptide elongation factor 2 has been researched along with Colonic Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cho, NJ; Liu, Z; Park, YS; Vasamsetti, BMK1
Gao, D; Li, JJ; Ma, X; Niu, A; Sun, W; Wei, X1

Other Studies

2 other study(ies) available for peptide elongation factor 2 and Colonic Neoplasms

ArticleYear
Muscarinic acetylcholine receptors regulate the dephosphorylation of eukaryotic translation elongation factor 2 in SNU-407 colon cancer cells.
    Biochemical and biophysical research communications, 2019, 08-20, Volume: 516, Issue:2

    Topics: Cell Line, Tumor; Colonic Neoplasms; Humans; Peptide Elongation Factor 2; Phosphoprotein Phosphatases; Phosphorylation; Protein Kinase C; Receptors, Muscarinic; Signal Transduction

2019
Enhanced anti-colon cancer immune responses with modified eEF2-derived peptides.
    Cancer letters, 2015, Dec-01, Volume: 369, Issue:1

    Topics: Animals; Caco-2 Cells; Colonic Neoplasms; Cytotoxicity, Immunologic; HLA-A2 Antigen; Humans; Immunologic Factors; Immunotherapy, Adoptive; Mice, Inbred C57BL; Mice, Nude; Mice, Transgenic; Neoplasm Transplantation; Peptide Elongation Factor 2; Peptide Fragments; Protein Binding; T-Lymphocytes, Cytotoxic

2015